<DOC>
	<DOCNO>NCT00691067</DOCNO>
	<brief_summary>We propose conduct placebo-controlled trial glucocorticoid receptor antagonist mifepristone Gulf War veteran ( GWV ) chronic multisymptom illness ( CMI ) examine effect physical mental health cognitive functioning . In addition , propose examine whether HPA axis biomarkers response mifepristone useful predictor clinical response .</brief_summary>
	<brief_title>A Controlled Trial Mifepristone Gulf War Veterans With Chronic Multisymptom Illness</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Veteran 1991 Gulf War Veteran meet criteria multisymptom illness Veteran lack capacity provide consent . Veteran major medical neurological disorder traumatic brain injury Veteran morning plasma cortisol level le 5 mcg/dl history adrenal insufficiency Veteran take oral corticosteroid Veteran lifetime diagnosis schizophrenia , schizoaffective disorder bipolar disorder Veteran psychiatrically hospitalize attempted suicide within previous 2 year Veteran current suicidal ideation Veteran pregnant breastfeeding plan become pregnant within year ( male female ) willing use appropriate form contraception study least 90 day post treatment . Women veteran disease uterus history family history uterine cancer Known allergy mifepristone</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>